Head-to-head
TMates vs Luvo Health
Compared on both medications across the eight dimensions this database records. They differ on 4 of those eight. TMates is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
TMates is $297 a month all-in for tirzepatide; Luvo Health is $339. Over twelve months that is $2,004 against $3,492. Value Scores are 55.3 and 50.4 out of 100.
Tirzepatide
Plan pages: TMates plans · Luvo Health plans
At 10 mg/week, TMates is $297 a month all-in and Luvo Health is $339 — $42 apart, or $504 across a year. Over twelve months the totals are $2,004 (prepaid term) and $3,492 (prepaid term).
TMates charges a flat $297 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
Luvo Health charges a flat $339 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | TMates | Rank | Luvo Health | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $297 | 16/31 | $339 | 22/31 | TMates by $42 |
| 5 mg | — | — | — | — | neither publishes |
| 7.5 mg | — | — | — | — | neither publishes |
| 10 mg | $297 | 12/27 | $339 | 16/27 | TMates by $42 |
| 12.5 mg | — | — | — | — | neither publishes |
| 15 mg | — | — | — | — | neither publishes |
TMates is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, TMates sits 10 of 27 on all-in monthly cost and Luvo Health sits 14. There are 3 other programs priced between them. The field median is $339 and the floor is $169, so both sit below the median. TMates is $128 above the cheapest tirzepatide program on record. Luvo Health is $170 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — TMates undercuts it by $152, Luvo Health by $110. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | TMates | Luvo Health | Cheaper |
|---|---|---|---|
| Month to month | $297 | $339 | TMates by $42 |
| 12-month term | $167 | $291 | TMates by $124 |
| Settled dose | TMates | Luvo Health | Difference |
|---|---|---|---|
| 2.5 mg | $3,564 | $4,068 | $504 apart |
| 10 mg | $3,564 | $4,068 | $504 apart |
TMates publishes no rate for 3-month term, 6-month term; Luvo Health publishes none for 3-month term, 6-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $3,564 on TMates and $4,068 on Luvo Health. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: TMates publishes no price at 2 of the 6 doses and Luvo Health publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 55.3 for TMates and 50.4 for Luvo Health, against a tirzepatide category floor of $169. TMates leads by 4.9 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| TMates | 39.8 | 10.5 | 0 | 5 | 55.3 |
| Luvo Health | 34.9 | 10.5 | 0 | 5 | 50.4 |
Semaglutide
Plan pages: TMates plans · Luvo Health plans
At 2.4 mg/week, TMates is $249 a month all-in and Luvo Health is $249, identical figures. Over twelve months the totals are $1,896 (prepaid term) and $2,328 (prepaid term).
TMates charges a flat $249 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Luvo Health charges a flat $249 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
TMates is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 51.8 for TMates and 51.8 for Luvo Health, against a semaglutide category floor of $129. TMates leads by 0.0 points, and the margin comes from structure rather than price alone.
Where the two programs differ
All-in monthly
TMates is cheaper month to month — $297 against $339, a gap of $42 every month, or $504 across a year if both rates hold.
Cancellation terms
Cancellation differs: TMates states Per provider terms, while Luvo Health states No-commitment 4-week option available; confirm annual plan refund terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
TMates asks for 12-month plan or month-to-month; substantial difference in rates; Luvo Health asks for 52-week (annual) plan billed as lump-sum ($3,497 tirz / $2,327 sema) OR 4-week rolling ($339/$249 per term, no commitment). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Twelve-month cost
Over twelve months the totals are $2,004 for TMates and $3,492 for Luvo Health. TMates is lower by $1,488 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both price by dose, so both advertised figures understate the cost of a titration year. Compare the ladders above rather than the headline rates.
Evidence status
Both figures carry the same evidence status, reported: sourced from dated third-party reporting; first-party capture pending. Neither is stronger than the other on provenance.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
TMates Official site
TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly named), so who actually makes the medication cannot be independently verified; commitment terms are 12-month plan or month-to-month; substantial difference in rates; cancellation is Per provider terms; availability is stated as Confirm at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture 2026-07-14
Watch: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Luvo Health Official site
Luvo Health publishes an openly available price ladder for compounded GLP-1s — semaglutide and tirzepatide — alongside longevity peptides. It names four dispensing pharmacy partners. Its 52-week (annual) plan offers the lowest per-month-equivalent rate; no-commitment 4-week terms cost materially more.
It does not publicly name its compounding pharmacy; the record shows Four named dispensing compounding pharmacies (specific names per provider materials), so who actually makes the medication cannot be independently verified; commitment terms are 52-week (annual) plan billed as lump-sum ($3,497 tirz / $2,327 sema) OR 4-week rolling ($339/$249 per term, no commitment); cancellation is No-commitment 4-week option available; confirm annual plan refund terms; availability is stated as All 50 states claimed; some services may not be available in all states per Luvo terms.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Luvo published $3,497 term total, verified 2026-08-08
Watch: Luvo publishes plan-TERM totals in weeks, not monthly prices; our monthly figures divide the term total by 12 calendar months, but 52 weeks = 13 four-week cycles, so the true per-cycle cost is slightly different. Luvo makes no third-party testing claim and its own evaluation does not include lab testing. Geographic availability is a qualified all-50-states claim. Reported status — RangeYourself verified 2026-08-08.
What neither record tells you
TMates does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm at intake
- no specific cancellation or refund terms
Luvo Health does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no named compounding pharmacy
Ask TMates and Luvo Health for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. TMates, Luvo Health carry a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. TMates publishes a twelve-month rate of $167 a month against $297 month-to-month; Luvo Health publishes a twelve-month rate of $291 a month against $339 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, TMates Official site wins this matchup. On the structural dimensions the two are close enough that the choice comes down to availability in your state and which intake you prefer.
Both figures should be checked at the provider's own checkout before you pay. TMates's tirzepatide price is reported as of 2026-07-14; Luvo Health's is reported as of 2026-08-08.
Questions
Is TMates or Luvo Health cheaper for tirzepatide?
TMates is cheaper on all-in monthly cost at 10 mg/week: $297 against $339, a difference of $42 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of TMates versus Luvo Health?
TMates works out to $2,004 across twelve months and Luvo Health to $3,492, on the plan terms each publishes.
Does TMates or Luvo Health raise the price as the dose goes up?
TMates: yes, it prices by dose. Luvo Health: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do TMates and Luvo Health differ?
4 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of TMates and Luvo Health names its pharmacy?
Neither. TMates records Partner 503A pharmacy (not publicly named) and Luvo Health records Four named dispensing compounding pharmacies (specific names per provider materials). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the TMates and Luvo Health prices?
TMates's tirzepatide figure is reported — sourced from dated third-party reporting; first-party capture pending — captured 2026-07-14. Luvo Health's is reported, captured 2026-08-08. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
TMates, at $249 a month all-in against $249 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: TMates official site · Luvo Health official site. Compounded tirzepatide and semaglutide are not FDA-approved products.